Investments in Basic Research for Pediatric Cancers: Developing Dinutuximab

NCI makes substantial investments in basic research, recognizing its fundamental importance in unraveling the complexities of pediatric cancers. A deeper understanding of cancer leads to new approaches for cancer prevention, screening, and treatment, like dinutuximab to treat neuroblastoma. Learn more about basic research in NCI’s Role in Cancer Research.